Bifogade filer
20231026 Corbion 3Q23 press release
Kurs
-1,03%
Kurs
-1,03%
Open
15,31
High
16,14
Low
14,62
Close
15,85
Kursutveckling under dagen för detta pressmeddelande
(EUR).
Kalender
| Est. tid* | ||
| 2025-07-31 | 07:00 | Kvartalsrapport 2025-Q2 |
| 2025-05-16 | N/A | X-dag ordinarie utdelning CRBN 0.64 EUR |
| 2025-05-14 | N/A | Årsstämma |
| 2025-02-27 | - | Bokslutskommuniké 2024 |
| 2024-08-08 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-17 | - | X-dag ordinarie utdelning CRBN 0.61 EUR |
| 2024-05-15 | - | Årsstämma |
| 2024-05-02 | - | X-dag bonusutdelning CRBN 0.1 |
| 2024-03-01 | - | Bokslutskommuniké 2023 |
| 2023-08-10 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-19 | - | X-dag ordinarie utdelning CRBN 0.56 EUR |
| 2023-05-17 | - | Årsstämma |
| 2023-03-03 | - | Bokslutskommuniké 2022 |
| 2022-08-10 | - | Kvartalsrapport 2022-Q2 |
| 2022-07-05 | - | Extra Bolagsstämma |
| 2022-05-20 | - | X-dag ordinarie utdelning CRBN 0.56 EUR |
| 2022-05-18 | - | Årsstämma |
| 2022-02-25 | - | Bokslutskommuniké 2021 |
| 2021-10-27 | - | Kvartalsrapport 2021-Q3 |
| 2021-07-20 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-21 | - | X-dag ordinarie utdelning CRBN 0.56 EUR |
| 2021-05-19 | - | Årsstämma |
| 2021-04-30 | - | Kvartalsrapport 2021-Q1 |
| 2021-03-05 | - | Bokslutskommuniké 2020 |
| 2020-10-12 | - | Kvartalsrapport 2020-Q3 |
| 2020-07-17 | - | Kvartalsrapport 2020-Q2 |
| 2020-07-01 | - | X-dag ordinarie utdelning CRBN 0.56 EUR |
| 2020-06-29 | - | Årsstämma |
| 2020-04-30 | - | Kvartalsrapport 2020-Q1 |
| 2020-01-13 | - | Bokslutskommuniké 2019 |
| 2019-11-01 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-07 | - | Kvartalsrapport 2019-Q2 |
| 2019-08-05 | - | Extra Bolagsstämma |
| 2019-04-26 | - | Kvartalsrapport 2019-Q1 |
2023-10-26 07:00:00
Corbion, the Amsterdam-listed sustainable ingredients company that champions preservation through the application of science, today publishes its results for the first nine months of 2023.
Key highlights first nine months 2023:
- Sales € 1,091.0 million; an organic increase of 2.6%
- Adjusted EBITDA € 142.8 million; an organic increase of 7.1%
- Operating profit € 75.9 million; an organic growth of 0.2%
- Organic growth core activities: Sales 4.2% & Adjusted EBITDA 12.3%
- Q3 2023:
- Sales € 353.0 million and Adjusted EBITDA € 46.0 million
- Organic growth core activities: Sales -2.2% & Adjusted EBITDA 6.1%
- Positive Free Cash Flow for the 2nd consecutive quarter as anticipated
Strategic Developments:
- Restructuring program underway to accelerate significant positive free cash flow delivery, including a full review to drive material improvements in operating expenses, capital program and working capital
- Broader auction process underway to divest the non-core emulsifier business in order to maximize value
- Strategic review of Corbion’s position in PLA
- Algae Ingredients roadmap 2025-2030 following strong growth prospect underway
- Continued focus on high growth, high value biomedical business
€ million | YTD 2023 | YTD 2022 | Total growth | Organic growth | ||
| Sales | 1,091.0 | 1,080.4 | 1.0% | 2.6% | ||
| Adjusted EBITDA | 142.8 | 142.8 | 0.0% | 7.1% | ||
| Adjusted EBITDA margin | 13.1% | 13.2% | ||||
| Operating profit | 75.9 | 91.7 | -17.2% | 0.2% | ||
| Core activities | ||||||
| Sales | 952.3 | 927.9 | 2.6% | 4.2% | ||
| Adjusted EBITDA | 121.5 | 116.6 | 4.2% | 12.3% | ||
| Adjusted EBITDA margin | 12.8% | 12.6% | ||||